Your browser doesn't support javascript.
loading
Effect of Human Papillomavirus Vaccine to Interrupt Recurrence of Vulvar and Anal Neoplasia (VIVA): A Trial Protocol.
Stankiewicz Karita, Helen C; Hauge, Kirsten; Magaret, Amalia; Mao, Constance; Schouten, Jeffrey; Grieco, Verena; Xi, Long Fu; Galloway, Denise A; Madeleine, Margaret M; Wald, Anna.
Afiliação
  • Stankiewicz Karita HC; Department of Medicine, University of Washington, Seattle.
  • Hauge K; Department of Medicine, University of Washington, Seattle.
  • Magaret A; Department of Biostatistics, University of Washington, Seattle.
  • Mao C; Division of Vaccine and Infectious Diseases, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Schouten J; Department of Laboratory Medicine, University of Washington, Seattle.
  • Grieco V; Department of Obstetrics and Gynecology, University of Washington, Seattle.
  • Xi LF; Department of Medicine, University of Washington, Seattle.
  • Galloway DA; Division of Vaccine and Infectious Diseases, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Madeleine MM; Department of Surgery, University of Washington, Seattle.
  • Wald A; Department of Pathology, University of Washington, Seattle.
JAMA Netw Open ; 2(4): e190819, 2019 04 05.
Article em En | MEDLINE | ID: mdl-30977845
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias do Ânus / Neoplasias Vulvares / Vacinas contra Papillomavirus / Recidiva Local de Neoplasia Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias do Ânus / Neoplasias Vulvares / Vacinas contra Papillomavirus / Recidiva Local de Neoplasia Idioma: En Ano de publicação: 2019 Tipo de documento: Article